Amgen Inc (AMGN)
Amgen Inc. is a global biopharmaceutical company focused on developing and manufacturing innovative medicines in areas such as oncology, nephrology, and inflammation. Founded in 1980, Amgen is known for its work in biologic therapies and has a strong portfolio of blockbuster drugs aimed at improving patient lives.
Dividend History
Investors can expect a dividend payout of $2.38 per share, scheduled to be distributed in 21 days on December 12, 2025
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 12, 2025 | $2.38 | 2025-11-21 | 2025-11-21 |
| September 12, 2025 | $2.38 | 2025-08-22 | 2025-08-22 |
| June 6, 2025 | $2.38 | 2025-05-16 | 2025-05-16 |
| March 7, 2025 | $2.38 | 2025-02-14 | 2025-02-14 |
| December 9, 2024 | $2.25 | 2024-11-18 | 2024-11-18 |
Dividends Summary
- Amgen Inc has issued 58 dividend payments over the past 14 years
- The most recent dividend was paid 70 days ago, on September 12, 2025
- The highest dividend payed out to investors during this period was $2.38 per share
- The average dividend paid during this period was $1.33 per share.
Company News
A comprehensive report analyzing 726 hospital care collaboration and licensing deals from 2016 to 2025, providing insights into deal terms, financial structures, and industry trends across various healthcare companies.
Tech stocks experienced a significant downturn on Tuesday, with the Nasdaq 100 dropping over 1%, while healthcare stocks like Eli Lilly and Amgen saw gains amid market rotation and uncertainty around Fed policy and upcoming earnings.
The healthcare sector is experiencing significant growth, with pharmaceutical companies like Eli Lilly and Novo Nordisk leading the way. Driven by strong quarterly results, drug pricing negotiations, and investor flight to safety, the sector has outperformed the S&P 500 by over seven times in the past month.
Amgen reported strong quarterly earnings, beating revenue and EPS estimates, with robust performance across drug portfolios and positive momentum signaling potential new stock highs.
The article discusses the Invesco Large Cap Value ETF (PWV), which provides broad exposure to the large-cap value segment of the market. It highlights the fund's investment strategy, performance, and risk profile, as well as compares it to similar ETFs like Schwab U.S. Dividend Equity ETF (SCHD) and Vanguard Value ETF (VTV).
